NGL Fine-Chem (NGLFINE) | Stock Overview & Key Data
NGL Fine-Chem Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹3,200.00 on June 15, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NGL Fine-Chem
NGLFINE
|
13.81B Small-cap | 17.19% | 32.28% | 42.63% | 133.76% | 122.63% | 190.36% | 86.41% | 63.13% | 63.13% | 63.13% | 63.13% |
|
GlaxoSmithKline
GLAXO
|
422.67B Large-cap | -3.19% | -13.28% | -11.99% | -17.96% | -13.88% | -35.63% | 50.14% | 45.44% | -39.87% | -9.78% | 324.98% |
|
Pfizer
PFIZER
|
218.82B Large-cap | -0.22% | -8.81% | -4.87% | -9.94% | -8.09% | -23.35% | 16.94% | -16.55% | 139.64% | 232.33% | 479.18% |
|
Senores
SENORES
|
41.04B Small-cap | 27.43% | 22.17% | 72.40% | 57.40% | 55.27% | 131.62% | 125.07% | 125.07% | 125.07% | 125.07% | 125.07% |
|
Sms Pharmaceuticals
SMSPHARMA
|
37.15B Small-cap | 2.49% | -5.59% | 3.24% | 16.68% | 20.59% | 54.90% | 314.99% | 124.70% | 340.29% | 1,909.70% | 1,070.48% |
|
TTK Healthcare
TTKHLTCARE
|
13.01B Small-cap | -2.04% | -2.14% | 6.84% | -16.44% | -14.48% | -30.05% | -29.39% | 43.44% | -3.20% | 117.54% | 214.14% |
Ownership & Short Interest
Calculate Your NGL Fine-Chem Investment Returns
Long-Term Investment Performance Analysis
NGL Fine-Chem stock price in Jul 2022 was ₹1,868.95, A ₹1,000.00 lump sum investment in NGL Fine-Chem made 3 years ago would be worth approximately ₹1,663.66 today, representing a solid return of 66.37%. This translates to an annualized return (CAGR) of 13.76%.
3 Years 11 Months Investment Scenario (Jul 2022 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NGLFINE's 52-week high and low?
- In the last 52 weeks, NGL Fine-Chem reached a high of ₹3,200.00 (on June 15, 2026) and a low of ₹980.00 (on June 20, 2025).
- What is the market cap and P/E ratio for NGLFINE?
- Curious about NGL Fine-Chem's size and valuation? Its market capitalization stands at 13.81B. When it comes to valuation, the P/E ratio (trailing twelve months) is 38.56, and the forward P/E (looking ahead) is N/A.
- Does NGLFINE pay dividends? If so, what's the yield?
- Yes, NGL Fine-Chem is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.26%, and the company has paid an average of ₹2.33 per share annually over the past 3 years.
- Who are NGL Fine-Chem's main competitors or similar companies to consider before investing?
When looking at NGL Fine-Chem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO422.67B Healthcare Drug Manufacturers - General -35.63% 50.14% Pfizer
PFIZER218.82B Healthcare Drug Manufacturers - General -23.35% 16.94% Senores
SENORES41.04B Healthcare Drug Manufacturers - General 131.62% 125.07% Sms Pharmaceuticals
SMSPHARMA37.15B Healthcare Drug Manufacturers - General 54.90% 314.99% TTK Healthcare
TTKHLTCARE13.01B Healthcare Drug Manufacturers - General -30.05% -29.39% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for NGL Fine-Chem Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of NGL Fine-Chem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.48%, the Debt to Equity ratio from the most recent quarter is 29.38, and its Gross Profit Margin stands at 53.33%.
- What is the recent revenue and earnings growth for NGLFINE?
- Looking at NGL Fine-Chem's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 43.10%, and quarterly earnings saw a YoY growth of 1,129.10%.
- How much of NGLFINE stock is held by insiders and institutions?
- Wondering who owns NGL Fine-Chem stock? Company insiders (like executives and directors) hold about 72.74% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.